Dose-volume histogram

Last updated

A dose-volume histogram (DVH) is a histogram relating radiation dose to tissue volume in radiation therapy planning. [1] DVHs are most commonly used as a plan evaluation tool and to compare doses from different plans or to structures. [2] DVHs were introduced by Michael Goitein (who introduced radiation therapy concepts such as the "beam's-eye-view," "digitally reconstructed radiograph," and uncertainty/error in planning and positioning, among others) and Verhey in 1979. [3] DVH summarizes 3D dose distributions in a graphical 2D format. In modern radiation therapy, 3D dose distributions are typically created in a computerized treatment planning system (TPS) based on a 3D reconstruction of a CT scan. The "volume" referred to in DVH analysis is a target of radiation treatment, a healthy organ nearby a target, or an arbitrary structure.

Contents

Types

DVHs can be visualized in either of two ways: differential DVHs or cumulative DVHs. A DVH is created by first determining the size of the dose bins of the histogram. Bins can be of arbitrary size, 0.005 Gy, 0.2 Gy or 1 Gy for instance. [4] The size is often a matter of tradeoff between accuracy and computational or memory cost (if we store the DVH in a database).

In a differential DVH, bar or column height indicates the volume of structure receiving a dose given by the bin. Bin doses are along the horizontal axis, and structure volumes (either percent or absolute volumes) are on the vertical. The differential DVH takes the appearance of a typical histogram. The total volume of the organ that receives a certain dose is plotted in the appropriate dose bin. [5] This volume is determined by the total number of voxels characterized by a specified range of dosage for the organ considered. The differential DVH provides information about changes in dose within the structure considered as well as visualization of minimum and maximum dose. [6]

The cumulative DVH is plotted with bin doses along the horizontal axis, as well. However, the column height of the first bin (e.g., [0, 1] Gy) represents the volume of structure receiving a dose greater than or equal to that dose. [5] The column height of the second bin (e.g., (1, 2] Gy) represents the volume of structure receiving greater than or equal to that dose, etc. With very fine (small) bin sizes, the cumulative DVH takes on the appearance of a smooth line graph. The lines always slope and start from top-left to bottom-right. For a structure receiving a very homogeneous dose (100% of the volume receiving exactly 10 Gy, for example) the cumulative DVH will appear as a horizontal line at the top of the graph, at 100% volume as plotted vertically, with a vertical drop at 10 Gy on the horizontal axis.

A cumulative DVH from a radiotherapy plan. Cumulative dose-volume histogram.jpg
A cumulative DVH from a radiotherapy plan.

A DVH used clinically usually includes all structures and targets of interest in the radiotherapy plan, each line plotted a different color, representing a different structure. The vertical axis is almost always plotted as percent volume (rather than absolute volume), as well. [7]

Drawbacks

Clinical studies have shown that DVH metrics correlate with patient toxicity outcomes. [8] A drawback of the DVH methodology is that it offers no spatial information; i.e., a DVH does not show where within a structure a dose is received. [9] Also, DVHs from initial radiotherapy plans represent the doses to structures at the start of radiation treatment. As treatment progresses and time elapses, if there are changes (i.e. if patients lose weight, if tumors shrink, if organs change shape, etc.), the original DVH loses its accuracy. [10]

Related Research Articles

<span class="mw-page-title-main">Radiation therapy</span> Therapy using ionizing radiation, usually to treat cancer

Radiation therapy or radiotherapy, often abbreviated RT, RTx, or XRT, is a treatment using ionizing radiation, generally provided as part of cancer therapy to either kill or control the growth of malignant cells. It is normally delivered by a linear particle accelerator. Radiation therapy may be curative in a number of types of cancer if they are localized to one area of the body, and have not spread to other parts. It may also be used as part of adjuvant therapy, to prevent tumor recurrence after surgery to remove a primary malignant tumor. Radiation therapy is synergistic with chemotherapy, and has been used before, during, and after chemotherapy in susceptible cancers. The subspecialty of oncology concerned with radiotherapy is called radiation oncology. A physician who practices in this subspecialty is a radiation oncologist.

<span class="mw-page-title-main">External beam radiotherapy</span> Treatment of cancer with ionized radiation

External beam radiation therapy (EBRT) is a compound word that refers to the use of a collimated beam of ionizing radiation from outside the body to treat a disease.

<span class="mw-page-title-main">Brachytherapy</span> Type of radiation therapy

Brachytherapy is a form of radiation therapy where a sealed radiation source is placed inside or next to the area requiring treatment. Brachy is Greek for short. Brachytherapy is commonly used as an effective treatment for cervical, prostate, breast, esophageal and skin cancer and can also be used to treat tumours in many other body sites. Treatment results have demonstrated that the cancer-cure rates of brachytherapy are either comparable to surgery and external beam radiotherapy (EBRT) or are improved when used in combination with these techniques. Brachytherapy can be used alone or in combination with other therapies such as surgery, EBRT and chemotherapy.

<span class="mw-page-title-main">Proton therapy</span> Medical Procedure

In medicine, proton therapy, or proton radiotherapy, is a type of particle therapy that uses a beam of protons to irradiate diseased tissue, most often to treat cancer. The chief advantage of proton therapy over other types of external beam radiotherapy is that the dose of protons is deposited over a narrow range of depth; hence in minimal entry, exit, or scattered radiation dose to healthy nearby tissues.

<span class="mw-page-title-main">Radiosurgery</span> Surgical Specialty

Radiosurgery is surgery using radiation, that is, the destruction of precisely selected areas of tissue using ionizing radiation rather than excision with a blade. Like other forms of radiation therapy, it is usually used to treat cancer. Radiosurgery was originally defined by the Swedish neurosurgeon Lars Leksell as "a single high dose fraction of radiation, stereotactically directed to an intracranial region of interest".

A monitor unit (MU) is a measure of machine output from a clinical accelerator for radiation therapy such as a linear accelerator or an orthovoltage unit. Monitor units are measured by monitor chambers, which are ionization chambers that measure the dose delivered by a beam and are built into the treatment head of radiotherapy linear accelerators.

Moist desquamation is a description of the clinical pattern seen as a consequence of radiation exposure where the skin thins and then begins to weep because of loss of integrity of the epithelial barrier and decreased oncotic pressure. Moist desquamation is a rare complication for most forms of radiology, however it is far more common in fluoroscopy where threshold doses lie between 10-15 Gy and increasingly common above 15 Gy. It has been noted that fractionation of fluoroscopic procedures significantly reduces the likelihood of moist desquamation occurring. In animal studies done on pig skin, moist desquamation was found to occur with a 50% of the time after a single dose of 28 Gy, however a 2×18 Gy fractionation scheme was needed to produce the same 50% occurrence.

<span class="mw-page-title-main">Multileaf collimator</span>

A multileaf collimator (MLC) is a Collimator or beam-limiting device that is made of individual "leaves" of a high atomic numbered material, usually tungsten, that can move independently in and out of the path of a radiotherapy beam in order to shape it and vary its intensity.

<span class="mw-page-title-main">Fast neutron therapy</span>

Fast neutron therapy utilizes high energy neutrons typically between 50 and 70 MeV to treat cancer. Most fast neutron therapy beams are produced by reactors, cyclotrons (d+Be) and linear accelerators. Neutron therapy is currently available in Germany, Russia, South Africa and the United States. In the United States, one treatment center is operational, in Seattle, Washington. The Seattle center uses a cyclotron which produces a proton beam impinging upon a beryllium target.

<span class="mw-page-title-main">Radiation treatment planning</span>

In radiotherapy, radiation treatment planning (RTP) is the process in which a team consisting of radiation oncologists, radiation therapist, medical physicists and medical dosimetrists plan the appropriate external beam radiotherapy or internal brachytherapy treatment technique for a patient with cancer.

Isocenter in aerial photography: it is a point where a line cuts an angle of 90 degree of tier/2. It is the point on the aerial photo platform that directly falls on a line half-way between the Principal point and the Nadir point. In imaging physics and radiation oncology, the isocenter is termed as the point in space through which the central rays of the radiation beams pass.

<span class="mw-page-title-main">Tomotherapy</span> Type of radiation therapy

Tomotherapy is a type of radiation therapy treatment machine. In tomotherapy a thin radiation beam is modulated as it rotates around the patient, while they are moved through the bore of the machine. The name comes from the use of a strip-shaped beam, so that only one “slice” of the target is exposed at any one time by the radiation. The external appearance of the system and movement of the radiation source and patient can be considered analogous to a CT scanner, which uses lower doses of radiation for imaging. Like a conventional machine used for X-ray external beam radiotherapy, a linear accelerator generates the radiation beam, but the external appearance of the machine, the patient positioning, and treatment delivery is different. Conventional linacs do not work on a slice-by-slice basis but typically have a large area beam which can also be resized and modulated.

Image-guided radiation therapy is the process of frequent imaging, during a course of radiation treatment, used to direct the treatment, position the patient, and compare to the pre-therapy imaging from the treatment plan. Immediately prior to, or during, a treatment fraction, the patient is localized in the treatment room in the same position as planned from the reference imaging dataset. An example of IGRT would include comparison of a cone beam computed tomography (CBCT) dataset, acquired on the treatment machine, with the computed tomography (CT) dataset from planning. IGRT would also include matching planar kilovoltage (kV) radiographs or megavoltage (MV) images with digital reconstructed radiographs (DRRs) from the planning CT.

Particle therapy is a form of external beam radiotherapy using beams of energetic neutrons, protons, or other heavier positive ions for cancer treatment. The most common type of particle therapy as of August 2021 is proton therapy.

Intraoperative electron radiation therapy is the application of electron radiation directly to the residual tumor or tumor bed during cancer surgery. Electron beams are useful for intraoperative radiation treatment because, depending on the electron energy, the dose falls off rapidly behind the target site, therefore sparing underlying healthy tissue.

<span class="mw-page-title-main">HPV-positive oropharyngeal cancer</span> Cancer of the throat

Human papillomavirus-positive oropharyngeal cancer, is a cancer of the throat caused by the human papillomavirus type 16 virus (HPV16). In the past, cancer of the oropharynx (throat) was associated with the use of alcohol or tobacco or both, but the majority of cases are now associated with the HPV virus, acquired by having oral contact with the genitals of a person who has a genital HPV infection. Risk factors include having a large number of sexual partners, a history of oral-genital sex or anal–oral sex, having a female partner with a history of either an abnormal Pap smear or cervical dysplasia, having chronic periodontitis, and, among men, younger age at first intercourse and a history of genital warts. HPV-positive OPC is considered a separate disease from HPV-negative oropharyngeal cancer.

Wolfgang Axel Tomé is a physicist working in Medicine as a researcher; inventor; and educator. He is noted for his contributions to the use of photogrammetry in high precision radiation therapy; his work on risk adaptive radiation therapy which is based on the risk level for recurrence in tumor sub-volumes using biological objective functions; and the development of hippocampal avoidant cranial radiation therapy techniques to alleviate hippocampal-dependent neurocognitive impairment following cranial irradiation.

Travel outside the Earth's protective atmosphere, magnetosphere, and gravitational field can harm human health, and understanding such harm is essential for successful crewed spaceflight. Potential effects on the central nervous system (CNS) are particularly important. A vigorous ground-based cellular and animal model research program will help quantify the risk to the CNS from space radiation exposure on future long distance space missions and promote the development of optimized countermeasures.

<span class="mw-page-title-main">Radiation-induced lumbar plexopathy</span> Type of nerve damage

Radiation-induced lumbar plexopathy (RILP) or radiation-induced lumbosacral plexopathy (RILSP) is nerve damage in the pelvis and lower spine area caused by therapeutic radiation treatments. RILP is a rare side effect of external beam radiation therapy and both interstitial and intracavity brachytherapy radiation implants.

<span class="mw-page-title-main">Side effects of radiotherapy on fertility</span>

The side effects of radiotherapy on fertility are a growing concern to patients undergoing radiotherapy as cancer treatments. Radiotherapy is essential for certain cancer treatments and often is the first point of call for patients. Radiation can be divided into two categories: ionising radiation (IR) and non-ionising radiation (NIR). IR is more dangerous than NIR and a source of this radiation is X-rays used in medical procedures, for example in radiotherapy.

References

  1. Drzymala, RE; Mohan, R; Brewster, L; Chu, J; et al. (1991). "Dose-volume histograms". International Journal of Radiation Oncology, Biology, Physics. 21 (1): 71–8. doi:10.1016/0360-3016(91)90168-4. PMID   2032898.
  2. Mayles, P.; Nahum, A.; Rosenwald, J.C., eds. (2007). Handbook of radiotherapy physics: theory and practice . New York: Taylor & Francis. p.  722. ISBN   9780750308601.
  3. Shipley, WU; Tepper, JE; Prout, GR Jr; Verhey, LJ; et al. (1979). "Proton radiation as boost therapy for localized prostatic carcinoma". JAMA . 241 (18): 1912–5. doi:10.1001/jama.1979.03290440034024. PMID   107338.
  4. Hasson, Brian F. (2013). "Dose Volume Histogram (DVH)". Encyclopedia of Radiation Oncology. p. 166. doi:10.1007/978-3-540-85516-3_659. ISBN   978-3-540-85513-2.
  5. 1 2 Khan, Faiz M. (2014). Khan's The Physics of Radiation Therapy. pp. 423–425. ISBN   978-1-4511-8245-3.
  6. Halperin, Edward C.; Perez, Carlos A.; Brady, Luther W. (2008), Perez and Brady's Principles and Practice of Radiation Oncology, Wolters Kluwer Health, Lippincott Williams & Wilkins, p. 231, ISBN   9780781763691
  7. Goitein, Michael (2008). Radiation oncology a physicist's-eye view . New York: Springer. p.  125. ISBN   9780387726458.
  8. Rodrigues, George; Lock, Michael; D'Souza, David; Yu, Edward; Van Dyk, Jake (May 2004). "Prediction of radiation pneumonitis by dose–volume histogram parameters in lung cancer—a systematic review". Radiotherapy and Oncology. 71 (2): 127–138. doi:10.1016/j.radonc.2004.02.015. PMID   15110445.
  9. Drzymala, R.E.; Mohan, R.; Brewster, L.; Chu, J.; Goitein, M.; Harms, W.; Urie, M. (May 1991). "Dose-volume histograms". International Journal of Radiation Oncology, Biology, Physics. 21 (1): 71–78. doi:10.1016/0360-3016(91)90168-4. PMID   2032898.
  10. Bhide, SA; Davies, M; Burke, K; McNair, HA; et al. (2010). "Weekly volume and dosimetric changes during chemoradiotherapy with intensity-modulated radiation therapy for head and neck cancer: A prospective observational study". International Journal of Radiation Oncology, Biology, Physics. 76 (5): 1360–8. doi:10.1016/j.ijrobp.2009.04.005. PMID   20338474.